Case Study Aventis Pharma - Implementation of a tool-based Capital Expenditure Process
Type
case study
Date Issued
2003-01-01
Author(s)
Senger, Enrico
Research Team
C>K>P, IWI4
Abstract
The Aventis Group, one of the largest pharmaceutical corporations worldwide, was created in 1999 by a merger between Hoechst AG and Rhône-Poulenc S.A. The Group's spectrum of products includes prescription drugs, vaccines and therapeutic proteins as well as animal health products. As part of the post-merger integration, Corporate Controlling introduced a tool-supported reporting process for investment controlling (capital expenditure) of all national organizations and business units. The figures are collected by the project managers. There is no direct hierarchical relationship between the project managers and the central controlling department, so in the context of a multinational corporation, preparation of the accounts can be seen as a collaborative process. Flat consolidation increases data quality (measured in terms of the variance compared to the accounting figures) twelve-fold. Technical system support improves the information available to decision-makers through individualized evaluations and improves the protection of sensitive data against unauthorized access. At the same time, 25% less time is required for preparing the quarterly reports.
Language
English
Keywords
Fallstudie
HSG Classification
not classified
Refereed
No
Publisher
Institut für Wirtschaftsinformatik, Universität St. Gallen
Publisher place
St. Gallen
Number
HSG / IWI / BECS / 10
Subject(s)
Division(s)
Eprints ID
65962
File(s)![Thumbnail Image]()
Name
Aventis%20Case%20Study%20engl%2025.rfa.pdf
Size
281.14 KB
Format
Adobe PDF
Checksum (MD5)
d6c722656557651c75e31bee501462b1